Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal. Collaboration With Epic Will Allow Clinicians to ...

A new type of technology may be on the way to changing how early cancer is detected.

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various ...

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...

A new study reveals that gut bacteria and metabolites may hold the key to detecting serious digestive diseases earlier and more easily. Using AI, scientists found that biomarkers linked to one ...

New Johns Hopkins research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early ...

PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects Prostate Cancer," (1) demonstrating clinical validation ...

Despite its reputation as a “young man’s cancer,” testicular cancer often flies under the radar. On average, people with testicles wait five or more months after noticing symptoms before bringing them ...

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...

Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support - and the more information included in AI prompting, the better its performance. This ...

Abstract: The Lung cancer remains to abundant as a leading reason of cancer-associated death worldwide, which necessitates early recognition for increasing survival rates. Standard diagnostic ...